Nobivac for Canine 1-DAPPv+Cv (25 Doses) - [Vaccine]

Nobivac Canine 1-DAPPv+Cv is a combination vaccine recommended for the vaccination of healthy dogs 6 weeks of age or older. It provides protection against six highly contagious canine diseases: canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus, and canine coronavirus.

Canine Distemper, Adenovirus Types 1 & 2, Parainfluenza, Parvovirus (CPV-2b), and Coronavirus Vaccine – Modified Live and Killed Virus

This proven 1-year vaccine offers broad-spectrum protection in a single, convenient dose. It combines both modified live and inactivated viral components to stimulate a strong immune response while supporting safety and efficacy.

Key Benefits of Nobivac Canine 1-DAPPv+Cv

• Protects against all known strains of canine parvovirus (CPV), including the emerging CPV-2c variant^1-3
• Formulated with CPV-2b, one of the most prevalent and protective field strains
• High antigenic mass (titer), low passage vaccine for enhanced immune stimulation
• Proven ability to override maternal antibodies for effective early-age vaccination³
• Dual adenovirus protection: type 1 (hepatitis) and type 2 (respiratory disease)
• Includes inactivated canine coronavirus for added respiratory and GI protection
• Comprehensive disease coverage in a single dose—ideal for routine core vaccination

Indications

• Indicated for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus types 1 and 2, parainfluenza virus, parvovirus, and coronavirus
• Recommended for use in dogs 6 weeks of age and older

Shake the vial of Nobivac Canine 1-Cv and aseptically transfer its contents into the vial of Nobivac Canine 1-DAPPv. Mix gently until the solution is fully dissolved. Use the entire rehydrated contents immediately.

Administer one 1 mL dose via subcutaneous or intramuscular injection. Initial vaccination may begin at 6 weeks of age. Repeat the dose every 2 to 4 weeks until the dog is at least 12 weeks old. A minimum of two doses is required for effective primary immunization.

Annual revaccination with a single dose is recommended. In line with the American Veterinary Medical Association (AVMA) guidelines on vaccination principles, vaccination schedules should be tailored based on the veterinarian-client-patient relationship.

• Administer via subcutaneous or intramuscular injection
• Begin at 6 weeks of age with repeat doses every 2–4 weeks until 12 weeks old
• Minimum of two 1 mL doses required for primary immunization
• Annual booster dose recommended

Safety Information:
Refer to the product label for complete safety instructions.

Precautions:

• Store between 2°C and 7°C (35°F–45°F)
• Do not freeze
• Do not mix with other vaccines
• Use new, non-chemically sterilized needles and syringes
• Burn vaccine containers and unused contents after use

Warnings:

• Contains gentamicin as a preservative
• Vaccinate only healthy, non-parasitized dogs
• Do not vaccinate pregnant bitches
• Administration of biological products may cause anaphylaxis or other immune-mediated hypersensitivity reactions.
  Antidote: Epinephrine, corticosteroids, and antihistamines may be indicated depending on the severity of the reaction
• The timing of maternal antibody decline varies by individual. Maternal antibodies can interfere with vaccine efficacy depending on antibody levels and absorption from colostrum.